Tyrosine kinase inhibitors and benzoylacrylamide derivatives
AssigneeMitsubishi Chemical Corporation
InventorsHisao Takayanagi, Yasunori Kitano, Tamaki Yano, Hiroe Umeki, Hiroto Hara
Life of this patent
Estimating the term…
Loading patent…
AssigneeMitsubishi Chemical Corporation
InventorsHisao Takayanagi, Yasunori Kitano, Tamaki Yano, Hiroe Umeki, Hiroto Hara
Estimating the term…
A pharmaceutical composition which comprises a pharmaceutically effective amount of a compound of the formula ##STR1## wherein R.sup.1 represents a hydrogen atom, R.sup.2 represents --(CH.sub.2).sub.m -A wherein m is an integer of 0 to 3, and A represents pyridyl which is unsubstituted or is substituted by C.sub.1 -C.sub.3 alkyl said alkyl being unsubstituted or substituted by phenyl, and R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 each independently represent a hydrogen atom, a halogen atom, C.sub.1 -C.sub.5 alkyl which is unsubstituted or is substituted with a halogen atom or --OR.sup.13 wherein R.sup.13 represents a hydrogen atom or C.sub.1 -C.sub.5 alkyl which is unsubstituted or is substituted with a halogen atom or phenyl, or when their adjacent substituents are taken together, they represent C.sub.1 -C.sub.3 oxyalkylene having one or two oxygen atoms; or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier therefor.
A pharmaceutical composition which comprises a pharmaceutically effective amount of a compound of the formula ##STR138## wherein R.sup.1 represents a hydrogen atom,
A method for suppressing the growth of cancer cells in mammals which comprises administering to a mammal in need of such treatment an effective amount of a compound of the formula ##STR139## wherein R.sup.1 represents a hydrogen atom,
A benzoylacrylamide derivative represented by the formula:
Dependencies are inferred from the claim text.